Literature DB >> 25512151

Cancer burden and control in the Western Pacific region: challenges and opportunities.

Cherian Varghese1, Marie Clem Carlos1, Hai-Rim Shin2.   

Abstract

BACKGROUND: Cancer has become a priority public health challenge in the Member States of the World Health Organization's (WHO) Western Pacific Region (WPR). Rapid and unplanned urbanization, demographic transition, and lifestyle changes are driving the increase in noncommunicable diseases (NCDs), which include cancer. The WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, targets a reduction in premature mortality from NCDs by 25% by 2025.
OBJECTIVES: The aim of this study was to review the epidemiology of cancer including cancer control efforts in the WPR.
METHODS: Information was primarily extracted from Globocan 2012, Cancer Incidence in Five Continents Vol. X, and the NCD country capacity survey carried out by the WHO in 2013. The WPR, with one-fourth of the world's population, has one-third of all cancers globally. Cancer cases in the WPR are expected to increase from 4.5 million new cases in 2012 to 6.4 million in 2025.
FINDINGS: In most of the low- and middle-income countries (LMICs) in Asia and in Pacific Island countries and areas, coverage of cancer registration is relatively low and they face many challenges in quality of cancer registry data. Eighty-five percent of LMICs have indicated the existence of a cancer control policy strategy and/or action plan. The predominance of lung, stomach, colorectal, breast, and cervical cancers makes control of the disease more amenable in the WPR. A relatively high ratio of mortality to incidence in LMICs reflects health-system limitations, especially in the diagnosis and management of cancer.
CONCLUSIONS: Strengthening cancer registration, tobacco control, and promotion of a healthy diet, as well as HBV and HPV vaccination, is the priority areas to reduce cancer burden. Health-system strengthening with a defined package of services at different levels, referral care, trained human resources, and appropriate technology is necessary to improve cancer management. Pain relief and palliative care are priorities as well. A well-planned national cancer control program with a strong component of surveillance and monitoring can help to reduce the cancer burden in LMICs and Pacific Island countries.
Copyright © 2014 Icahn School of Medicine at Mount Sinai. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pacific Island countries and areas; World Health Organization Western Pacific Region; cancer prevention and control; low- and middle-income countries

Mesh:

Substances:

Year:  2014        PMID: 25512151     DOI: 10.1016/j.aogh.2014.09.015

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  14 in total

1.  Cyproheptadine use in hepatocellular carcinoma.

Authors:  Mao-Chih Hsieh; Wei-Hua Lee; Alexander Th Wu; Jyh-Ming Chow; Chia-Lun Chang; Kevin Sheng-Po Yuan; Szu-Yuan Wu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Modeling the Trend Changes of Liver Cancer Mortality in the 6 WHO Regions.

Authors:  Seyedeh Fatemeh Musavi Ezmareh; Kamran Mehrabani; Hadi Raeisi Shahraki
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

3.  Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013.

Authors:  Zhixun Yang; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Changfa Xia; He Li; Li Wang; Yanhong Wang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

4.  Implications of Radiotherapy Utilization in Korea from 2010 to 2019.

Authors:  Jeongshim Lee; Woo Chul Kim; Won Sup Yoon; Chai Hong Rim
Journal:  J Korean Med Sci       Date:  2021-05-10       Impact factor: 2.153

5.  Long-term survival trends of gastric cancer patients between 1972 and 2011 in Qidong.

Authors:  Yong-Sheng Chen; Jian-Guo Chen; Jian Zhu; Yong-Hui Zhang; Lu-Lu Ding
Journal:  Chin J Cancer       Date:  2015-10-19

Review 6.  Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.

Authors:  Obinna I Ekwunife; James F O'Mahony; Andreas Gerber Grote; Christoph Mosch; Tatjana Paeck; Stefan K Lhachimi
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

7.  miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.

Authors:  Jin Huang; Yijing He; Howard L Mcleod; Yanchun Xie; Desheng Xiao; Huabin Hu; Pan Chen; Liangfang Shen; Shan Zeng; Xianli Yin; Jie Ge; Li Li; Lanhua Tang; Jian Ma; Zihua Chen
Journal:  BMC Cancer       Date:  2017-12-22       Impact factor: 4.430

8.  Health disparities are associated with gastric cancer mortality-to-incidence ratios in 57 countries.

Authors:  Ming-Chang Tsai; Chi-Chih Wang; Hsiang-Lin Lee; Cheng-Ming Peng; Tzu-Wei Yang; Hsuan-Yi Chen; Wen-Wei Sung; Chun-Che Lin
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

9.  Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on Early Gastric Cancer Risk in Korea: A Case-Control Study.

Authors:  Sarah Yang; Yoon Park; Jeonghee Lee; Il Ju Choi; Young Woo Kim; Keun Won Ryu; Joohon Sung; Jeongseon Kim
Journal:  Cancer Res Treat       Date:  2017-01-19       Impact factor: 4.679

10.  Assessing the Relationship between Chronic Lymphoid Leukemia Mortality Rates and Human Development Index: A 26-Year Trend Analysis Using Location-Scale Mixed Effects Model.

Authors:  Parisa Rezanejad Asl; Farid Zayeri; Alireza Moghisi
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.